Montreal Cognitive Assessment (MoCA): Difference between revisions

No edit summary
No edit summary
Line 13: Line 13:
* Older adults<ref>Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14.</ref>
* Older adults<ref>Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14.</ref>
* Alzheimer's dementia<ref>Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013 Dec;61(12):2181-5.</ref>
* Alzheimer's dementia<ref>Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013 Dec;61(12):2181-5.</ref>
* Vascular cognitive impairment
* Vascular cognitive impairment<ref>Koski L. Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis. 2013;36(1):6-18.</ref>
* Stroke
* Stroke<ref>Toglia J, Fitzgerald KA, O'Dell MW, Mastrogiovanni AR, Lin CD. The Mini-Mental State Examination and Montreal Cognitive Assessment in persons with mild subacute stroke: relationship to functional outcome. Arch Phys Med Rehabil. 2011 May;92(5):792-8. </ref>
* Parkinson's disease
* Parkinson's disease<ref>Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord. 2008 May 15;23(7):1043-6. </ref>
* Huntington's disease
* Huntington's disease<ref>Bezdicek O, Majerova V, Novak M, Nikolai T, Ruzicka E, Roth J. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease. Appl Neuropsychol Adult. 2013 Jan 1;20(1):33-40.</ref>
* Schizophrenia
* Schizophrenia<ref>Yang Z, Abdul Rashid NA, Quek YF, Lam M, See YM, Maniam Y, Dauwels J, Tan BL, Lee J. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophr Res. 2018 Sep;199:58-63.</ref>


== Method of Use  ==
== Method of Use  ==

Revision as of 06:31, 29 March 2022

Original Editor - Arnold Fredrick D'Souza

Top Contributors - Arnold Fredrick D'Souza, Lucinda hampton, Kim Jackson and Sultan Eylem Demirhan  

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (29/03/2022)

Objective[edit | edit source]

It was developed by Dr. Ziad S. Nasreddine and colleagues for quickly screening individuals for mild cognitive impairment.[1]

Intended Population[edit | edit source]

It can be used on the following populations:

  • Older adults[2]
  • Alzheimer's dementia[3]
  • Vascular cognitive impairment[4]
  • Stroke[5]
  • Parkinson's disease[6]
  • Huntington's disease[7]
  • Schizophrenia[8]

Method of Use[edit | edit source]

Reference[edit | edit source]

Evidence[edit | edit source]

Reliability[edit | edit source]

Validity[edit | edit source]

Responsiveness[edit | edit source]

Miscellaneous[edit | edit source]

Links[edit | edit source]

References[edit | edit source]

  1. ↑ Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9.
  2. ↑ Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14.
  3. ↑ Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013 Dec;61(12):2181-5.
  4. ↑ Koski L. Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis. 2013;36(1):6-18.
  5. ↑ Toglia J, Fitzgerald KA, O'Dell MW, Mastrogiovanni AR, Lin CD. The Mini-Mental State Examination and Montreal Cognitive Assessment in persons with mild subacute stroke: relationship to functional outcome. Arch Phys Med Rehabil. 2011 May;92(5):792-8.
  6. ↑ Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord. 2008 May 15;23(7):1043-6.
  7. ↑ Bezdicek O, Majerova V, Novak M, Nikolai T, Ruzicka E, Roth J. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease. Appl Neuropsychol Adult. 2013 Jan 1;20(1):33-40.
  8. ↑ Yang Z, Abdul Rashid NA, Quek YF, Lam M, See YM, Maniam Y, Dauwels J, Tan BL, Lee J. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophr Res. 2018 Sep;199:58-63.
Retrieved from "https://www.physio-pedia.com/index.php?title=Montreal_Cognitive_Assessment_(MoCA)&oldid=299025"